This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Maze Therapeutics, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Victoria Anne Assimon: Innovator in APOL1 Inhibitors
Introduction
Victoria Anne Assimon is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of APOL1 inhibitors. With a total of 2 patents to her name, her work is paving the way for advancements in treating APOL1-mediated diseases.
Latest Patents
Victoria's latest patents focus on APOL1 inhibitors and methods of use. These patents provide compounds of formula (II) and detail methods for preparing these compounds, including stereoisomers, tautomers, and pharmaceutically acceptable salts. Additionally, her patents outline methods for inhibiting APOL1 and treating related diseases, disorders, or conditions in individuals.
Career Highlights
Victoria is currently employed at Maze Therapeutics, Inc., where she continues to innovate and develop new therapeutic solutions. Her expertise in the field has positioned her as a key player in the pharmaceutical industry.
Collaborations
Throughout her career, Victoria has collaborated with notable colleagues, including Patrick Sang Tae Lee and Todd Jonathan August Ewing. These partnerships have further enhanced her research and development efforts.
Conclusion
Victoria Anne Assimon is a trailblazer in the field of APOL1 inhibitors, with her innovative patents contributing to the advancement of medical treatments. Her work at Maze Therapeutics, Inc. exemplifies her commitment to improving healthcare through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile